NL-OMON51440已完成不适用
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants - FIH of DNL919 in healthy volunteers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Healthy male participants and healthy female participants of non childbearing
- •potential aged between 18 and 55 years, inclusive, with a body mass index (BMI)
- •between 18.5 and 32 kg/m2, inclusive
排除标准
- •Women of childbearing potential will be excluded in this study because
- •reproductive toxicity studies have not yet been performed. Also, participants
- •with any history of clinically significant neurological, psychiatric, endocrine
- •(including diabetes mellitus), pulmonary, cardiovascular, gastrointestinal,
- •hepatic, pancreatic, renal, metabolic, hematologic, immunologic, or allergic
- •disease, or other major disorders.
研究者
相似试验
已完成
1 期
Study of ZYN002 (cannabidiol gel) in 40 Healthy VolunteersMental Health - Other mental health disordersNeurological - EpilepsyMusculoskeletal - OsteoarthritisHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersEpilepsyFragile X SyndromeOsteoarthritisACTRN12618000183280Zynerba Pharmaceuticals Pty. Ltd.40
已完成
1 期
A first in human study assessing the safety and pharmacokinetics (blood levels) of RA101495.ACTRN12615001143516Clinical Network Services Pty Ltd40
已完成
1 期
A first in Human single-Center Study To Evaluate the effectiveness and Safety Of A Live Attenuated Dengue Vaccine (KD-382) In Healthy AdultsInfection - Other infectious diseasesInflammatory and Immune System - Normal development and function of the immune systemDengue FeverACTRN12618001027202KM Biologics Co., Ltd.60
已完成
不适用
A Phase I, Randomized, Placebo-controlled, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Activity of Repeated Intranasal Administration of Ampligen® (Poly I:Poly C12U) in Healthy SubjectsCoronaCOVID-19SARS-CoV-210047438NL-OMON50834AIM ImmunoTech Inc.40
已完成
1 期
A single and multiple dose study of M127101 in healthy subjectsasal polyp accompanies eosinophilic chronic rhinosinusitisJPRN-jRCT2071230019Tomoyuki Nishiura16